Primary Wave 1 had extended 3 & 5th Sub-waves, respectively.
Trade Price: $2.35
This stock has already been a double plus some and I believe it has a lot more room to run. See related idea for a more in-depth analysis.
Charts:
Monthly:
Weekly:
Daily:
1HR:
Good Entry: $3.91-$4.39
Will update.
-AB
Note
ST Target: $9.00LT Target: $19.00
Note
LOS ANGELES --(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CV Sciences, Inc. ("CV Sciences" or the "Company") (OTC: CVSI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission .Investors who purchased the Company's shares between June 19, 2017 and August 20, 2018 , inclusive (the "Class Period"), are encouraged to contact the firm before October 23, 2018 .
Note
Not sure how much merit this lawsuit has but it's worth noting. Shareholder should be happy for the company's growth.Note
LAS VEGAS , Sept. 25, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) preeminent supplier and manufacturer of hemp-derived phytocannabinoids including industry leading brand, PlusCBD Oil™ , announced today that it has introduced PlusCBD Oil™ Gummies at the Natural Product Expo East 2018. A new category of PlusCBD Oil™ products, PlusCBD Oil™ Gummies are offered in two tasty flavors, Cherry Mango and Citrus Punch. A line extension of our Gold Formula line with no artificial ingredients, each gummy contains 5 mg of CBD and a mere 1.5 g of sugar. Gluten free, vegan friendly, and non-GMO, these new products support healthy balance of the body and mind.
“We are pleased to introduce PlusCBD Oil™ Gummies to our existing line of industry leading hemp extract products that include balms, sprays, drops, capsules, and softgels,” stated Joseph Dowling , Chief Executive Officer of CV Sciences . “We are committed to innovation of our PlusCBD Oil™ products, and as the demand for CBD infused products continues to grow, it is important to expand our wide variety of products to suit all customer preferences. We foresee PlusCBD Oil™ Gummies being a solid revenue driving category for our Company.”
Note
It's amazing how Fibonacci time-frames usually co-inside with news items or events...Note
Above is exactly what I was talking about in the related idea. CBD is being put or made into everything.Note
1D: Elders Force Index shows a Strong divergence.Note
CVSI is about to breakout...Note
1 Minute chart shows Sub-Waves 1, 2, 3, and 4 ending.Note
Extending 3rdNote
Sleeper Stock...Once CVSI hits the Nasdaq this thing will be a rocket ship.
Note
Closed at high -> rally Monday...Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.